REDHILL BIOPHARMA LTD.

Codice
RDHL
Risorse esterne
Opinione della community
Prezzo Variazione Volume
10.22 +0.69 €
(+7.24%)
18057
P/E Obiettivo ad 1anno
0 30.25 €

Compra - Vendi

0
Tutte le tue transazioni per questo titolo

Devi effettuare l'accesso


Grafico

Altri utenti che hanno investito

Transations in last week
Buy: 19
Sell : 9

Demi9996 boss66 Cerbero Marco Di Folco Imperator Sipra Antonio Peluso Vlad Alexandru Riky3695 AngerManagement

Commenti


Notizie

Redhill Biopharma Ltd. (RDHL) Valuation According To Analysts - UK Market News

05/06/2015 – Redhill Biopharma Ltd. was upgraded to “buy” by analysts at Zacks. They now have a USD 16 price target on the stock. The share price of Redhill Biopharma Ltd. (RDHL) was down -0.98% during the last trading session, with a day high of 0.00. Leggi

The RedHill Biopharma Ltd. (RDHL) gets “Sell” status at The Zacks Investment Research - DailyQuint

RedHill Biopharma Ltd. (NASDAQ:RDHL) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Thursday. According to Zacks ... The company had a trading volume of 33,878 shares. The stock has a 50 day ...altro » Leggi

The RedHill Biopharma Ltd. to Post FY2016 Earnings of ($2.40) Per Share, Roth Capital Forecasts (RDHL) - DailyQuint

RedHill Biopharma Ltd. (NASDAQ:RDHL) – Analysts at Roth Capital cut their FY2016 earnings per share estimates for shares of RedHill Biopharma in a research note issued on Monday. Roth Capital ... 42,325 shares of the stock traded hands. RedHill ... Leggi

Consensus Notes on Redhill Biopharma Ltd. (NASDAQ:RDHL) - Liberty News

In the most recent trading session, Redhill Biopharma Ltd. (NASDAQ:RDHL) shares saw a move of -1.9962%. Covering Wall Street analysts have a consensus target price of $30.2500 on the stock. Target predictions might differ vastly from analyst to analyst.altro » Leggi

Gearing Up For a Bull Run? Analysts Weigh in on Redhill Biopharma Ltd. (NASDAQ:RDHL) - Wall Street Beacon

Wall Street analysts covering Redhill Biopharma Ltd. (NASDAQ:RDHL) shares are predicting that the stock will trade between $26 and $36 within the next year. This is the top price point and lowest from the analysts taken into consideration by Zacks ...altro » Leggi

Broker Outlook For The Week Ahead Redhill Biopharma Ltd. (RDHL) - Fiscal Standard

Currently 4 analysts have outstanding research reports on Redhill Biopharma Ltd. (RDHL), according to the reports 1 analysts rate the stock “Buy”, 3 “Outperform”, 0 “Underperform”, 0 “Sell”, while 0 “Hold”. The most recently updated ratings and price ...altro » Leggi

The RedHill Biopharma's (RDHL) “Buy” Rating Reiterate at FBR & Co - DailyQuint

RedHill Biopharma Ltd. (NASDAQ:RDHL)'s stock had its “buy” rating reaffirmed by stock analysts at FBR & Co in a note issued to investors on Wednesday. A number of other ... The company's stock had a trading volume of 51,860 shares. The stock's market ... Leggi

Concordia (CXRX) Deal Great News for RedHill (RDHL) Shareholders - Economic Calendar

Specialty pharmaceuticals developer RedHill Biopharma Ltd (NASDAQ:RDHL) is trading about three percent higher this morning – currently up 31 cents from Friday's closing price of $10.46. The Israel-based drug maker announced early this morning that it ... Leggi

To Buy Or Sell Redhill Biopharma Ltd. (RDHL) On Latest Analyst Consensus - Fiscal Standard

05/06/2015 – Redhill Biopharma Ltd. was upgraded to “buy” by analysts at Zacks. They now have a USD 16 price target on the stock. The share price of Redhill Biopharma Ltd. (RDHL) was down -1.80% during the last trading session, with a day high of 0.00. Leggi

RedHill Biopharma Ltd. (NASDAQ:RDHL) announced that U.S. FDA granted RHB-104 QIDP designation - Benchmark Monitor

On last trading day, RedHill Biopharma Ltd. (NASDAQ:RDHL) traded 96924 shares and was closed at $10.55 per share. Company stock is -36.22% away from its one year high and is moving 30.25% ahead of its one year low. Stock monthly performance is ...altro » Leggi